Clinical TrialID 7298

Acetate and Age-associated Arterial Dysfunction

NCT05424263

Aging|Vascular Stiffness|Vascular Dilation

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7298
Evidence Id
7298
Core Evidence Id
7298
Source Clinical Trial Id
7289
Herb2 Clinical Trial Id
HBCT007289
Nct Id
NCT05424263
Title
Acetate and Age-associated Arterial Dysfunction
Status
Recruiting
Phase
Phase 2
Study Result
No
Study Condition
Aging|Vascular Stiffness|Vascular Dilation
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Calcium Acetate Oral Solution|DRUG: Calcium Carbonate Oral Suspension
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
66
Outcome Measure
Change in Brachial Artery Flow-Mediated Dilation, Nitric oxide-mediated endothelium dependent dilation (vascular endothelial function) will be assessed at baseline and end-intervention by flow-mediated dilation of the brachial artery determined using high-resolution ultrasonography (Canon Xario 200) and analyzed with a commercially available software package (Vascular Analysis Tools, Medical Imaging Applications, LLC). Brachial artery flow-mediated dilation will be assessed by measuring brachial artery diameter and forearm blood flow at baseline and for 2 minutes following reactive hyperemia induced by 5 minutes of forearm blood flow occlusion (upper forearm cuff placement). Data will be expressed as a percent change in arterial diameter from pre-cuff inflation diameter, and then as a change in this % from baseline to end-intervention., 12 weeks
Sponsor Collaborator
University of Colorado, Denver
Funded By
OTHER
Location
University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States
Other Id
22-0473
Start Date
2022-09-29
Primary Completion Date
2025-07-01
Completion Date
2025-09-01
First Posted
2022-06-21
Results First Posted
Last Update Posted
2024-03-15
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05424263
Title Cn
Title En
Acetate and Age-associated Arterial Dysfunction
Bilingual Status
semi_complete